78 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
3 Jun 24
Additional proxy soliciting materials
6:28pm
of the Company or an ISO Affiliate (except in the event of the U.S. Participant’s death or Disability, in which case a 12-month period applies). The Company … or service of the Company, except as follows: (a) in the case of the death of a Recipient, any vested Award held by him at the date of death
8-K
EX-99.1
q100k9tch eifi
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
8-K
EX-99.2
2fis79lzktie
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
S-8
EX-10.1
8h7pr
25 Jun 21
Registration of securities for employees
4:31pm
8-K
EX-99.1
9gskumaemmfwvxhye
25 Jun 21
Regulation FD Disclosure
4:12pm
8-K
EX-99.1
qv1opglzc l4chw5
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
l0pt gyqgj
10 May 21
Definitive proxy
4:06pm
PRE 14A
b234luux6e yxh
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-3.2
8c9yv5xx0
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
8-K
EX-99.1
uocqh0vq40aly
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
EX-10.16
ble9cgiasanxfs6iet2
24 Feb 21
Annual report
4:09pm